Frontlight ResearchEarly access
Not yet taking people in NetherlandsPhase 4
Imaging hidden glioblastoma cells in the brain with iron particles
Tests iron oxide particles in MRI scans to spot glioblastoma cells spreading into healthy brain.
Key facts
- Who runs it
- Stichting Radboud universitair medisch centrum
- Where
- Nijmegen, NetherlandsSee the site
- Registry title
- Unravelling the invisiBle infiltRating cOmponeNT Of glioblaStomA Using mRi USpio (BRONTOSAURUS)
- Status
- Not yet recruiting
- Phase
- Phase 4
- People taking part
- 15 people, planned
- Started
- 1 Jan 2025
- Expected to end
- 1 Jan 2027
- Type of study
- Interventional
- Record updated
- 2 December 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with suspected glioblastoma, a type of brain tumour. It studies how far the tumour spreads into healthy brain tissue using a special MRI scan with iron oxide particles.
- Age
- 18 to 75 years
- Sex
- Men and women can join.
- Disease stage
- Suspected glioblastoma.
- Earlier treatment
- People must be able to have brain surgery and/or chemotherapy with radiation.
Main reasons for not taking part
- Younger than 18 years
- People who are not fit enough for surgery
- Tumours that cannot be treated with brain surgery
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Diagnosed with suspected glioblastoma
- Age between 18-75 years
- Eligible for neurosurgical resection and/or chemoradiation therapy
Who cannot take part
- Patients unfit for surgery or lesions unsuitable for neurosurgical treatment
- Younger than 18 years
Where in Netherlands
- Radboud universitair medisch centrum StichtingNijmegen, NetherlandsNot yet recruiting
About the trial
What the trial wants to find out
To what extent, do GBMs infiltrate healthy brain tissue and can we use ultrasmall superparamagnetic iron oxide particles to visualize co-opting infiltrating tumor cells in an attempt to predict regions of tumor recurrence?
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Official title
- Unravelling the invisiBle infiltRating cOmponeNT Of glioblaStomA Using mRi USpio (BRONTOSAURUS)
- Plain-language title
- Imaging hidden glioblastoma cells in the brain with iron particlesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 2 December 2024